ClinicalTrials.gg
RecruitingNCT06428149Updated Mar 28, 2025

Three Types of Papilla Incision in Periodontal Surgery

An interventional study of Midline interproximal soft-tissue incision and Marginal approach by palatal incision in Periodontitis, Periodontal Diseases and Periodontal Pocket, sponsored by Universidad de Murcia. Recruiting at 1 site in Spain. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-03-28.

Primary conditionPeriodontal PocketRegistry: PeriodontitisReclassifiedWhy we changed it
Registry
Periodontitis — the first condition term the registry derived for this study.
ClinicalTrials.gg
Periodontal Pocket
Why
  1. The study's listed conditions name Periodontal Pocket, a narrower term within Periodontitis.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Universidad de Murcia · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2026, 4 months ago, but the record still lists the study as recruiting.
  • Registered 11 months after the study started (first participant enrolled Jun 2023, registered May 2024).
  • Started Jun 2023; still recruiting 3 years 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Three types of papilla incision in periodontal reconstruction techniques will be compared.

02

Conditions studied

  • Periodontitis
  • Periodontal Diseases
  • Periodontal Pocket

Browse trials for

03

In context

Periodontal Pocket Reclassified

130 studies on the registry are indexed under Periodontal Pocket; 35 are open to participants now.

This study's planned enrollment of 30 is close to the median of 30 across 113 interventional studies indexed under Periodontal Pocket.

Browse Periodontal Pocket studies →

Lead sponsor

Universidad de Murcia is the lead sponsor of 81 studies on the registry; 18 are open to participants now.

Compared within Periodontal Pocket, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Periodontitis. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients diagnosed with periodontal disease.
  • Active residual pockets associated with intraosseous defects that did not resolve with non-surgical treatment after 1 year of maintenance.
  • Intraosseous lesions with probing depth greater than 5 mm or extension of the radiographic defect greater than 4 mm.
  • Plaque index and bleeding index less than 30%.

Exclusion criteria

Exclusion Criteria:

  • Systemic disease that contraindicates periodontal surgery.
  • Pregnant women.
  • Third molars or teeth with incorrect endodontic or restorative treatment.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Midline interproximal soft-tissue incision

    Marginal approach by midline interproximal soft tissue incision and a limited papilla elevation to the buccal aspect will be made for treating isolated periodontal defect. Enamel matrix derivates will be applied on the debrided root surfaces.

    Procedure: Midline interproximal soft-tissue incision

  • Active comparator
    Marginal approach by palatal incision

    A small incision in the palatal aspect and a limited papilla elevation to the buccal aspect will be made for treating isolated periodontal defect. Enamel matrix derivates will be applied on the debrided root surfaces.

    Procedure: Marginal approach by palatal incision

  • Active comparator
    Minimally invasive surgical technique

    The incision of the defect-associated papilla will be performed according to the principles of the papilla preservation techniques. Enamel matrix derivates will be applied on the debrided root surfaces. Stable primary closure of the flaps will be obtained with internal modified mattress sutures.

    Procedure: Minimally invasive surgical technique

Interventions

  • ProcedureMidline interproximal soft-tissue incision

    Firstly, the marginal tissue will be elevated around the periodontal defect, through the tunneling of the tissues, entering through the gingival sulcus and the periodontal pocket of the teeth involved in the defect periodontal. Once the marginal tissues have been disinserted to full thickness, the soft supra-alveolar component of the defect to be reconstructed will be stretched, in a buccal direction, with a blunt instrument, applying pressure on the lingual aspect. Visualizing the midpoint of the interproximal tissue, the papilla will be dissected at its midpoint, entering through the mesial aspect, with the scalpel blade perpendicular to the central axis of the teeth.

  • ProcedureMarginal approach by palatal incision

    First, an incision will be made in the palatal aspect of the interproximal papilla, at the base of the papilla, parallel to the axis of the tooth until touching the palatine alveolar crest, in order to detach and move the papilla from its base, attached to the vestibular flap. From the palatal incision the interproximal tissue will be elevated towards the buccal until the buccal bone crest is exposed.

  • ProcedureMinimally invasive surgical technique

    The defect will be accessed through an incision at the base of the papilla on the vestibular aspect. Depending on the anatomy of the interproximal space, two types of incisions will be made: simplified papilla preservation flap (SPPF) when the width of the interproximal space is equal to or less than 2 mm, or modified papilla preservation technique (MPPT) when the width is greater than 2 millimeters. The interproximal incision will extend intrasulcular on the lingual and buccal aspect of the teeth adjacent to the defect, and mesio-distally it will extend as necessary to allow access to the defect and its debridement. The papilla will move from its base towards the palatine.

06

What researchers measure

Primary outcomes

  1. Bleeding on probing

    Bleeding on probing could be positive or negative

    Time frame: 12 months

  2. Clinical attachment level (CAL)

    Clinical attachment level will be assessed with a periodontal probe, measured in mm from the cementoenamel junction (CEJ) to the bottom of the pocket

    Time frame: 12 months

  3. Probing pocket depth (PD)

    Probing pocket depth will be assessed with a periodontal probe, measured in mm from the gingival margin to the bottom of the pocket

    Time frame: 12 months

  4. Recession (REC)

    Recession, will be assessed with a periodontal probe, measured in mmm on the buccal aspect, from the CEJ to the gingival margin zenith.

    Time frame: 12 months

  5. Location of the tip of the papillae (TP)

    Location of the tip of the papillae. Taking as reference the level of the mid-axis of the tooth, will be measured the distance from the CEJ at the zenith of the tooth to the tip of the papilla. A positive value will be recorded when the tip of the papillae is located coronally to the CEJ and a negative value otherwise. This outcome will be assessed with a periodontal probe and measured in mm.

    Time frame: 12 months

  6. Keratinized tissue width (KT)

    Keratinized tissue width will be assessed with a periodontal probe, measured in mm on the buccal aspect, from the gingival margin to the mucogingival line.

    Time frame: 12 months

Secondary outcomes

  1. Supra-alveolar attachment gain (SUPRA-AG)

    Subtracting the 12 month CAL from the intrasurgically Bone Component-CEJ will provide the SUPRA-AG result.

    Time frame: 12 months

07

Study locations

1 of 1 sites recruiting
  • Centro Odontologico Del Sureste Slp
    Murcia, 30007, Spain
    Recruiting
    • JOSÉ ANTONIO MORENO-RODRIGUEZ, DDS · Contact+34 620538483
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2023 (actual). Primary completion is estimated for Jul 2026, 37 months after the start.

Of 59 non-industry interventional studies with no phase under Periodontal Pocket, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 26. This study's planned 37 months is above that.

Counting every sponsor, half of 63 studies reached it within 16 months; a quarter within 9 and three quarters within 26.

How these figures are worked out, and which studies are left out of them.

Registered
May 20, 2024
First posted
May 24, 2024
StartActual
Jun 1, 2023
Primary completionEst.
Jul 1, 2026
CompletionEst.
Dec 1, 2026
Last update
Mar 28, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 28, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06428149
Lead sponsor
Universidad de Murcia
Responsible party
Antonio José Ortiz Ruiz, MD (Professor and researcher, Universidad de Murcia) — Principal investigator
First posted
May 24, 2024
Start date
Jun 1, 2023
Primary completion
Jul 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Mar 28, 2025

Study contacts

ANTONIO J ORTIZ-RUIZ, MD
Contact
ajortiz@um.es
+34 868888581

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion